Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.7.0, indicating a backend/page template update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-09-15T20:49:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as the study condition, and a related topics section has been added featuring MedlinePlus Genetics. This enhances the disease context and provides quick access to related information for researchers and participants.
    Difference
    0.2%
    Check dated 2026-09-08T19:38:26.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This indicates a minor backend/documentation update.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:10.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a minor site software update.
    Difference
    0.1%
    Check dated 2026-08-11T18:50:57.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, replacing the previous v3.6.3. This represents a small behind-the-scenes update to the page/template without changing its content.
    Difference
    0.1%
    Check dated 2026-07-28T14:37:52.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page loses the explicit disease name and a related topics section, removing key disease context and associated education resources for readers.
    Difference
    0.2%
    Check dated 2026-07-21T11:35:13.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.